Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiumei Liu

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 11, 2021
Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction NetworkDi Chen, Yiran Zhang, Wen Wang, et al.
Thrombosis Journal|November 21, 2023
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort studyWenlin Xu, Jiana Chen, Shuyi Wu, et al.
International Journal of Cardiology|February 15, 2023
New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulantsJiana Chen, Meina Lv, Wenlin Xu, et al.
Cardiovascular Drugs and Therapy|April 8, 2022
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from ChinaShuyi Wu, Nianxu Huang, Xia Chen, et al.
Thrombosis Journal|April 4, 2023
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort studyShuyi Wu, Chengfu Guan, Wenlin Xu, et al.
Arthritis Research & Therapy|April 12, 2018
Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled studyYang-Zhong Zhou, Li-Dan Zhao, Hua Chen, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 21, 2020
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical TrialJinmei Su, Mengtao Li, Lan He, et al.
Clinical Rheumatology|October 28, 2021
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 studyJinmei Su, Mengtao Li, Lan He, et al.
Frontiers in Pharmacology|December 28, 2020
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time PointsJinmei Su, Mengtao Li, Lan He, et al.
Rheumatology and Therapy|November 22, 2021
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III StudyYanying Liu, Shengyun Liu, Lin Liu, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 11, 2021
Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction NetworkDi Chen, Yiran Zhang, Wen Wang, et al.
Thrombosis Journal|November 21, 2023
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort studyWenlin Xu, Jiana Chen, Shuyi Wu, et al.
International Journal of Cardiology|February 15, 2023
New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulantsJiana Chen, Meina Lv, Wenlin Xu, et al.
Cardiovascular Drugs and Therapy|April 8, 2022
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from ChinaShuyi Wu, Nianxu Huang, Xia Chen, et al.
Thrombosis Journal|April 4, 2023
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort studyShuyi Wu, Chengfu Guan, Wenlin Xu, et al.
Arthritis Research & Therapy|April 12, 2018
Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled studyYang-Zhong Zhou, Li-Dan Zhao, Hua Chen, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 21, 2020
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical TrialJinmei Su, Mengtao Li, Lan He, et al.
Clinical Rheumatology|October 28, 2021
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 studyJinmei Su, Mengtao Li, Lan He, et al.
Frontiers in Pharmacology|December 28, 2020
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time PointsJinmei Su, Mengtao Li, Lan He, et al.
Rheumatology and Therapy|November 22, 2021
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III StudyYanying Liu, Shengyun Liu, Lin Liu, et al.
Pageof 25